Your browser doesn't support javascript.
loading
Men's Sexual Health Questionnaire score changes vs spontaneous sexual adverse event reporting in men treated with dutasteride/tamsulosin combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A post hoc analysis of a prospective, randomised, placebo-controlled study.
Roehrborn, Claus G; Rosen, Raymond C; Manyak, Michael J; Palacios-Moreno, Juan Manuel; Wilson, Timothy H; Lulic, Zrinka; Giuliano, François.
Afiliação
  • Roehrborn CG; Department of Urology, UT Southwestern Medical Centre, University of Texas, Dallas, TX, USA.
  • Rosen RC; HealthCore/New England Research Institutes, Watertown, MA, USA.
  • Manyak MJ; GSK, Washington, DC, USA.
  • Palacios-Moreno JM; GSK, Madrid, Spain.
  • Wilson TH; PAREXEL International, Durham, NC, USA.
  • Lulic Z; GSK, Brentford, UK.
  • Giuliano F; Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, Garches, France.
Int J Clin Pract ; 74(5): e13480, 2020 May.
Article em En | MEDLINE | ID: mdl-31927774

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hiperplasia Prostática / Sintomas do Trato Urinário Inferior / Saúde Sexual / Dutasterida / Tansulosina Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hiperplasia Prostática / Sintomas do Trato Urinário Inferior / Saúde Sexual / Dutasterida / Tansulosina Idioma: En Ano de publicação: 2020 Tipo de documento: Article